- Sep 1
MAC Clinical Research appointed to conduct psychedelic trial for Major Depressive Disorder (MDD)
SmallPharma, a biotechnology company focused on short-acting psychedelic-assisted therapies for mental health conditions has enlisted MAC...
- Aug 26
Continuing our legacy for more than 30 years with our free memory clinics
At MAC, we have a proud history of establishing one of the UK’s first ever memory clinics back in 1988. Whilst we now operate as a...
- Jul 25
Could psychedelic research be a promising new step in treating mental health disorders?
The next generation of treatment? Could psychedelic research be a promising new step in treating mental health disorders like depression,...
- May 10
MAC receives recognition by BritishAmerican Business (BAB) as part of Transatlantic Growth Campaign
The Transatlantic Growth campaign (TAG) is an annual campaign that highlights and celebrates businesses that demonstrate growth and...
- Apr 22
MAC Featured in The Guardian Newspaper
MAC Clinical Research featured in a recent Guardian article titled: Clinical trials: how taking the pills may pay those bills. The...
- Jan 25
MAC Opens US Office/Study Site
To continue to meet the research needs of our clients and their patients across the globe, MAC Clinical Research has arrived in the...
- Jun 16, 2021
MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase...
- Mar 11, 2021
MHRA approve launch of DemeRX’s Phase I/IIa trial of ibogaine HCl for treatment of OUD
MAC are excited to be collaborating with DemeRx on their phase 1 trial of Opioid Use Disorder.
- Jan 19, 2021
Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
MAC’s Senior Director of Early Phase Research, Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s...
- Jun 1, 2020
MAC Achieves Cyber Essentials Certification
MAC Clinical Research the UK’s leading clinical trials organisation is proud to announce achieving Cyber Essentials security industry certif
